Collegium Pharmaceutical Income Statement (2016-2025) | COLL

Income Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue -0.07M0.41M1.30M2.17M3.56M4.38M10.79M63.75M73.06M70.18M73.43M74.52M75.04M72.94M74.20M76.51M78.06M79.18M76.27M87.72M82.94M78.84M27.36M83.75M123.55M127.01M129.62M144.77M135.55M136.71M149.75M144.92M145.28M159.30M181.95M177.76M188.00M209.36M
Cost of Revenue 0.03M0.18M0.37M0.58M0.55M1.09M43.11M46.84M46.01M29.73M49.16M48.65M46.75M49.09M37.52M29.69M30.98M31.98M32.12M32.70M32.73M28.70M35.26M71.19M68.17M79.83M67.36M61.72M56.40M55.12M53.47M54.47M62.51M83.66M80.43M79.62M80.19M
Gross Profit 0.38M1.12M1.80M2.98M3.82M9.70M20.64M26.22M24.17M43.70M25.35M26.39M26.19M25.11M38.99M48.36M48.19M44.29M55.60M50.24M46.11M-1.33M48.50M52.36M58.84M49.79M77.40M73.83M80.31M94.63M91.46M90.81M96.79M98.29M97.32M108.38M129.17M
Operating items
Amortization - Intangibles 3.69M3.69M3.69M3.69M10.29M16.80M16.80M16.80M16.80M16.80M16.80M16.80M18.92M37.50M37.55M42.28M37.47M37.46M36.32M34.51M34.52M34.52M40.80M55.47M55.47M55.47M55.47M
Research & Development 4.06M3.25M3.33M2.13M2.18M2.07M2.19M2.27M2.24M1.91M2.25M2.99M2.46M2.49M2.40M2.67M2.49M2.14M2.47M2.93M3.46M1.45M1.61M3.98M
Selling, General & Administrative 11.53M23.57M25.37M22.85M22.06M22.76M25.09M31.58M31.28M33.45M30.45M32.35M28.93M30.07M25.09M31.26M29.32M26.43M26.82M31.48M30.37M30.51M26.60M54.53M41.25M38.37M38.03M52.77M38.19M35.30M32.94M41.98M43.34M61.95M63.09M76.42M73.64M67.10M
Restructuring Costs 4.58M8.62M7.81M7.80M9.47M13.29M9.80M10.90M
Other Operating Expenses 0.03M0.18M0.37M0.58M0.55M1.09M43.11M46.84M46.01M29.73M11.57M-206.99M-8.62M-7.81M5.39M-51.77M-14.07M-10.16M-10.92M
Operating Expenses 15.59M26.85M28.88M25.35M24.82M25.38M28.38M76.96M80.35M81.36M62.43M35.34M31.39M32.56M27.49M33.93M31.82M28.57M29.30M34.41M33.83M31.96M32.79M58.51M41.25M38.37M38.03M52.77M38.19M35.30M32.94M41.98M43.34M61.95M60.18M75.64M73.28M67.08M
Operating Income -15.59M-26.44M-27.58M-23.18M-21.26M-13.43M-17.58M-13.21M-7.29M-11.19M11.00M-9.99M-5.01M-6.38M-2.37M5.06M16.55M19.63M15.00M21.19M16.41M14.15M-34.12M-10.02M11.11M20.47M11.76M24.63M35.63M45.01M61.69M49.47M47.47M34.84M38.11M21.69M35.10M62.09M
EBIT -15.59M-26.44M-27.58M-23.18M-21.26M-13.43M-17.58M-13.21M-7.29M-11.19M11.00M-9.99M-5.01M-6.38M-2.37M5.06M16.55M19.63M15.00M21.19M16.41M14.15M-34.12M-10.02M11.11M20.47M11.76M24.63M35.63M45.01M61.69M49.47M47.47M34.84M38.11M21.69M35.10M62.09M
Non-operating items
Interest & Investment Income -0.00M0.02M0.10M0.14M0.17M0.18M0.26M0.39M0.55M0.49M0.53M0.53M0.49M0.38M0.21M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M1.03M2.75M4.03M4.54M4.30M4.49M4.40M3.28M1.81M2.23M2.38M3.12M
Other Non Operating Income -0.07M-0.00M0.02M0.10M0.14M0.17M0.18M23.50M-47.01M-4.14M
Non Operating Income -0.07M-0.00M0.02M0.10M0.14M0.17M0.18M
Net income details
EBT -15.65M-26.45M-27.54M-23.08M-21.12M-13.26M-17.40M-18.65M-13.06M-16.50M9.09M-9.70M-9.70M-6.11M-2.20M0.45M8.30M11.57M7.26M15.47M10.99M9.04M-38.88M-15.84M-6.65M1.43M-7.79M-17.56M17.80M28.78M46.71M36.62M29.10M15.58M17.27M3.12M17.02M43.44M
Tax Provisions 0.25M0.25M0.28M0.30M-0.19M-61.85M0.99M-13.84M-2.77M-1.46M0.97M-0.59M-0.13M4.79M8.15M14.77M8.91M9.49M6.25M4.73M0.70M5.04M11.93M
Profit After Tax -15.65M-26.44M-27.56M-23.08M-21.12M-13.26M-17.40M-18.65M-13.06M-16.50M9.09M-9.70M-4.71M-6.11M-2.20M0.45M8.06M11.29M6.96M15.66M72.84M8.05M-25.03M-13.07M-5.19M0.46M-7.20M-17.43M13.01M20.63M31.94M27.71M19.61M9.34M12.54M2.42M11.98M31.51M
Income from Continuing Operations -15.65M-26.45M-27.54M-23.08M-21.12M-13.26M-17.40M-18.65M-13.06M-16.50M9.09M-9.70M-9.70M-6.11M-2.20M0.20M8.06M11.29M6.96M15.66M72.84M8.05M-25.03M-13.07M-5.19M0.46M-7.20M-17.43M13.01M20.63M31.94M27.71M19.61M9.34M12.54M2.42M11.98M31.51M
Consolidated Net Income -15.65M-26.45M-27.54M-23.08M-21.12M-13.26M-17.40M-18.65M-13.06M-16.50M9.09M-9.70M-9.70M-6.11M-2.20M0.20M8.06M11.29M6.96M15.66M72.84M8.05M-25.03M-13.07M-5.19M0.46M-7.20M-17.43M13.01M20.63M31.94M27.71M19.61M9.34M12.54M2.42M11.98M31.51M
Income towards Parent Company -15.65M-26.45M-27.54M-23.08M-21.12M-13.26M-17.40M-18.65M-13.06M-16.50M9.09M-9.70M-9.70M-6.11M-2.20M0.20M8.06M11.29M6.96M15.66M72.84M8.05M-25.03M-13.07M-5.19M0.46M-7.20M-17.43M13.01M20.63M31.94M27.71M19.61M9.34M12.54M2.42M11.98M31.51M
Net Income towards Common Stockholders -15.65M-26.45M-27.54M-23.08M-21.12M-13.26M-17.40M-18.65M-13.06M-16.50M9.09M-9.70M-4.71M-6.11M-2.20M0.45M8.06M11.29M6.96M16.83M74.01M8.05M-25.03M-13.07M-5.19M0.46M-7.20M-17.43M13.01M20.63M31.94M27.71M19.61M9.34M12.54M2.42M11.98M31.51M
Additional items
EPS (Basic) -0.68-1.13-1.02-0.79-0.72-0.45-0.54-0.57-0.40-0.500.27-0.29-0.14-0.18-0.070.010.230.330.200.452.060.23-0.73-0.39-0.150.01-0.21-0.510.380.610.990.860.600.290.390.080.381.00
EPS (Weighted Average and Diluted) -0.29-0.14-0.18-0.060.010.230.320.200.411.790.22-0.73-0.39-0.150.01-0.21-0.510.340.530.820.710.520.270.360.070.340.84
Shares Outstanding (Weighted Average) 23.51M23.53M23.53M28.61M29.45M29.46M29.57M32.56M32.99M33.04M33.22M33.25M33.31M33.39M33.47M33.53M34.05M34.34M34.53M34.58M34.76M35.25M35.56M34.57M33.38M33.97M34.13M33.57M34.07M34.59M34.73M32.61M31.96M32.72M32.21M32.25M31.49M32.14M31.50M
Shares Outstanding (Diluted Average) 33.33M35.07M
EBITDA -15.59M-26.44M-27.58M-23.18M-21.26M-13.43M-17.58M-13.21M-7.29M-11.19M11.00M-9.99M-5.01M-6.38M-2.37M5.06M16.55M19.63M15.00M21.19M16.41M14.15M-34.12M-10.02M11.11M20.47M11.76M24.63M35.63M45.01M61.69M49.47M47.47M34.84M38.11M21.69M35.10M62.09M
Interest Expenses 0.07M0.00M-0.02M5.70M6.16M5.87M2.40M0.23M0.24M0.23M0.21M4.82M8.26M8.06M7.74M5.72M5.42M5.12M4.76M5.83M17.76M19.05M20.57M21.43M21.86M20.77M19.28M17.34M15.59M18.39M22.65M20.79M20.46M21.77M
Tax Rate 54.67%2.96%2.42%4.19%10.97%35.61%17.50%21.89%68.09%7.60%0.75%26.91%28.31%31.62%24.33%32.62%40.08%27.41%22.58%29.62%27.46%